Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4865147
Max Phase: Preclinical
Molecular Formula: C80H114N8O20
Molecular Weight: 1507.83
Molecule Type: Unknown
Associated Items:
ID: ALA4865147
Max Phase: Preclinical
Molecular Formula: C80H114N8O20
Molecular Weight: 1507.83
Molecule Type: Unknown
Associated Items:
Canonical SMILES: O=C(CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCC(=O)NCCCCC(=O)Nc1ccc2c(c1)[C@@]13CCN4CC5=CCO[C@H]6CC(=O)N2[C@H]1[C@H]6[C@H]5C[C@H]43)NCCCCC(=O)Nc1ccc2c(c1)[C@@]13CCN4CC5=CCO[C@H]6CC(=O)N2[C@H]1[C@H]6[C@H]5C[C@H]43
Standard InChI: InChI=1S/C80H114N8O20/c89-69(81-17-3-1-5-71(91)83-57-7-9-63-61(47-57)79-15-19-85-53-55-11-23-107-65-51-73(93)87(63)77(79)75(65)59(55)49-67(79)85)13-21-95-25-27-97-29-31-99-33-35-101-37-39-103-41-43-105-45-46-106-44-42-104-40-38-102-36-34-100-32-30-98-28-26-96-22-14-70(90)82-18-4-2-6-72(92)84-58-8-10-64-62(48-58)80-16-20-86-54-56-12-24-108-66-52-74(94)88(64)78(80)76(66)60(56)50-68(80)86/h7-12,47-48,59-60,65-68,75-78H,1-6,13-46,49-54H2,(H,81,89)(H,82,90)(H,83,91)(H,84,92)/t59-,60-,65-,66-,67-,68-,75-,76-,77-,78-,79+,80+/m0/s1
Standard InChI Key: MQMVLFAEBALNCN-VQVSISRWSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1507.83 | Molecular Weight (Monoisotopic): 1506.8149 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Zlotos DP, Abdelmalek CM, Botros LS, Banoub MM, Mandour YM, Breitinger U, El Nady A, Breitinger HG, Sotriffer C, Villmann C, Jensen AA, Holzgrabe U.. (2021) C-2-Linked Dimeric Strychnine Analogues as Bivalent Ligands Targeting Glycine Receptors., 84 (2.0): [PMID:33596384] [10.1021/acs.jnatprod.0c01030] |
Source(1):